Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome

被引:0
作者
Paola Concolino
Roberta Rizza
Karl Hackmann
Ida Paris
Angelo Minucci
Elisa De Paolis
Giovanni Scambia
Cecilia Zuppi
Evelin Schrock
Ettore Capoluongo
机构
[1] Catholic University of Sacred Heart,Laboratory of Molecular Biology, Institute of Biochemistry and Clinical Biochemistry
[2] Technische Universitaet Dresden,Institut fuer Klinische Genetik, Medizinische Fakultaet Carl Gustav Carus
[3] German Cancer Consortium (DKTK),Department of Obstetrics and Gynecology
[4] German Cancer Research Center (DKFZ),undefined
[5] National Center for Tumor Diseases (NCT),undefined
[6] Catholic University,undefined
来源
Breast Cancer Research and Treatment | 2017年 / 164卷
关键词
BRCA1/BRCA2; Large genomic rearrangements; Hereditary breast and ovarian cancer syndrome; MAQ/MLPA assays; ARRAY CGH;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:497 / 503
页数:6
相关论文
共 164 条
[1]  
Thompson D(2004)The genetic epidemiology of breast cancer genes J Mammary Gland Biol Neoplasia 9 221-236
[2]  
Easton D(2006)The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability Oncogene 25 5864-5874
[3]  
Gudmundsdottir K(2011)Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation Breast Cancer Res Treat 125 325-349
[4]  
Ashworth A(2006)Gross rearrangements in BRCA1 but not BRCA2 play a notable role in predisposition to breast and ovarian cancer in high-risk families of German origin Cancer Genet Cytogenet 168 44-49
[5]  
Sluiter MD(2009)Genomic rearrangements in BRCA1 and BRCA2: a literature review Genet Mol Biol 32 437-446
[6]  
van Rensburg EJ(2002)Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot Am J Hum Genet 70 858-865
[7]  
Preisler-Adams S(1996)Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1 Genome Res 6 1029-1049
[8]  
Schönbuchner I(2014)A preliminary Quality Control (QC) for next generation sequencing (NGS) library evaluation turns out to be a very useful tool for a rapid detection of BRCA1/2 deleterious mutations Clin Chim Acta 437 72-77
[9]  
Fiebig B(2015)Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review Expert Rev Mol Diagn 15 1383-1403
[10]  
Welling B(2014)Advanced tools for BRCA1/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection Clin Chem Lab Med 52 1119-1127